Plain-English translation of NCT07030881 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a simple plastic spacer device attached to your inhaler can help you breathe better and avoid serious flare-ups of asthma or COPD. You're already taking three medications together in your inhaler — the spacer is designed to make sure more of that medication actually reaches your lungs instead of staying in your mouth and throat. The study will compare people using the spacer with people using their inhaler the regular way, all over three months.
Many older adults have trouble using inhalers properly because of age-related hand-strength or coordination issues, which means less medication reaches their lungs and more side effects occur. This medication is meant to reduce dangerous flare-ups, but if it's not being delivered correctly, it can't work as well as it should.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either continue using your inhaler normally or to use the same inhaler with a spacer device attached. The spacer group will receive extra training on how to properly attach and use the spacer. Over three months, the research team will track whether you have any serious flare-ups, check how well your lungs are working, and ask about your technique and how satisfied you are with your treatment. You'll likely have a few visits or check-ins during this time.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China